Aruba vs Sint Maarten (Dutch part): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Aruba
0.2%
in 2024
Sint Maarten (Dutch part)
0.2%
in 2024
Aruba rank
99th
Sint Maarten (Dutch part) rank
99th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Aruba
- Sint Maarten (Dutch part)
How they compare
Aruba currently reports 0.2% against 0.2% in Sint Maarten (Dutch part), a difference of 0.0%.
Across all 10 years both countries report, Sint Maarten (Dutch part) has been ahead every year.
Aruba ranks 99th and Sint Maarten (Dutch part) ranks 99th of 247 countries.
Head to head by decade
| Decade | Aruba | Sint Maarten (Dutch part) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Aruba or Sint Maarten (Dutch part)?
- Aruba, at 0.2% against 0.2% in Sint Maarten (Dutch part) as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Aruba and Sint Maarten (Dutch part)?
- 0.0%, with Aruba ahead.
- How many years of comparable data are there for Aruba and Sint Maarten (Dutch part)?
- 10 years are reported by both, from 2015 to 2024.
- How do Aruba and Sint Maarten (Dutch part) rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Aruba ranks 99th and Sint Maarten (Dutch part) ranks 99th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.